11 earlier Form 4 trades (code P or S) here by this insider (11 buys), the last on May 27, 2022.
-2.0% median (-2.4% mean) 90-day return after 3 previous buys.
The trade is 3.0% of the 233,811 shares held after it.
No other insider bought within 30 days.
Insider activity: President and CEO Riley John A III bought about $71.7K of CULL on Nov 16, 2023, the largest insider purchase at the company since 2022.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM CULL
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM CULL
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$934.0K
operating cash flow minus capex, 2023-04-01 to 2024-03-31
Free cash flow, TTM CULL
FY Dec 2023
$2.2M
FY Dec 2022
$4.0M
FY Dec 2021
$3.9M
FY Dec 2020
n/a
Mar 2024
$130.0K
Dec 2023
-$1.6M
Sep 2023
$1.8M
Jun 2023
$625.0K
Mar 2023
$1.4M
Dec 2022
-$238.0K
Sep 2022
$1.7M
Jun 2022
$1.8M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity CULL
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt CULL
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+3.6%
TTM net income over average of 2023-03-31 and 2024-03-31
Return on equity CULL
FY Dec 2023
+3.9%
FY Dec 2022
+4.2%
FY Dec 2021
+2.2%
FY Dec 2020
+6.4%
Mar 2024
+3.6%
Dec 2023
+3.9%
Sep 2023
+4.1%
Jun 2023
+3.9%
Mar 2023
+4.2%
Dec 2022
+4.2%
Sep 2022
+3.9%
Jun 2022
+3.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.9%
TTM net income over average of 2023-03-31 and 2024-03-31
Return on assets CULL
FY Dec 2023
+0.9%
FY Dec 2022
+1.1%
FY Dec 2021
+0.5%
FY Dec 2020
+1.1%
Mar 2024
+0.9%
Dec 2023
+0.9%
Sep 2023
+1.0%
Jun 2023
+1.0%
Mar 2023
+1.1%
Dec 2022
+1.1%
Sep 2022
+1.0%
Jun 2022
+0.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CULL
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CULL
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
34.40x
close 2026-10-26 over four quarters of diluted EPS, 2023-04-01 to 2024-03-31
P/E, trailing CULL
FY Dec 2023
19.94x
FY Dec 2022
19.15x
FY Dec 2021
51.17x
FY Dec 2020
22.00x
Mar 2024
19.90x
Dec 2023
19.94x
Sep 2023
18.10x
Jun 2023
19.04x
Mar 2023
17.62x
Dec 2022
19.15x
Sep 2022
20.11x
Jun 2022
33.26x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value CULL
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
Sep 2022
n/a
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+0.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield CULL
FY Dec 2023
+2.9%
FY Dec 2022
+4.7%
FY Dec 2021
+4.3%
FY Dec 2020
n/a
Mar 2024
+1.3%
Dec 2023
+2.9%
Sep 2023
+4.7%
Jun 2023
+4.5%
Mar 2023
+6.0%
Dec 2022
+4.7%
Sep 2022
+6.3%
Jun 2022
+6.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -18%, PEG needs growth
PEG, trailing CULL
FY Dec 2023
n/a
FY Dec 2022
0.13x
FY Dec 2021
n/a
FY Dec 2020
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
1.92x
Jun 2023
0.29x
Mar 2023
0.14x
Dec 2022
0.13x
Sep 2022
0.31x
Jun 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Risk and compliance
83
Inputs
Short interest, % of shares outstanding (no float on file)+0.2% · 83 pct, sector of 374
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
5 not measured: Financial health, Growth, Insider conviction, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.